Arch Therapeutics Inc (ARTH)

[Regis999]

More ARCH Articles

New article (9/22/16) on AC5 in Surgery Products Magazine: "Arch Therapeutics Delivers New Method For Controlling Bleeding"


http://www.surgicalproductsmag.com/article/2016/09/arch-therapeutics-delivers-new-method-controlling-bleeding

"...The initial goal is to stop bleeding, which is also called hemostasis but the company has aspirations to leverage its technology to address leakage of other bodily fluids. There’s also an organizational commitment to trauma care and military medicine.

The first derivation of the technology Arch Therapeutics is pursuing is the AC5 Topical Hemostatic Device™.

The company recently got topline data from its first study of safety and performance in humans. It involved 46 patients, each of whom had at least two skin lesions on their arms or torso. After being removed, the wound defects, which were left behind, were treated with either AC5™ or a sham saline solution applied to it. The patients were reassessed after seven days and again after 30 days."




http://oracledispatch.com/2016/09/24/steady-progress-at-arch-therapeutics-inc-otcmktsarth/

Steady Progress at Arch Therapeutics Inc (OTCMKTS:ARTH)
By Jermaine Farmer - September 24, 2016